Chinese hospitals are selling de-identified patient data to fuel the AI boom (asia.nikkei.com)

Chinese hospitals are capitalizing on their extensive patient records by selling de-identified medical data, transforming previously underutilized information into a valuable asset for the rapidly expanding AI sector. This practice is becoming increasingly significant as AI companies, pharmaceutical manufacturers, and research institutes in China seek access to large datasets to enhance their machine learning models and improve healthcare innovations. The strict requirements for de-identification ensure patient privacy while allowing hospitals to generate revenue. As these datasets become more accessible, they could accelerate advancements in AI applications in medicine, such as predictive analytics for patient outcomes, personalized treatment plans, and breakthroughs in drug discovery. This strategy not only boosts the AI industry but also fosters an environment where evidence-based healthcare solutions can thrive, potentially reshaping the future of medical research and treatment in China.